In previous studies, the investigators have seen that carefully-selected Lactobacillus strains are a good alternative to antibiotics for the treatment of lactational mastitis. The objective of this new study is to check if they can also have a preventive role when administered to women with a history of mastitis with one or more previous infants. Since the investigators have also realized that peripartum antibiotherapy (mainly GBS-targeting intrapartum prophylaxis)is a predisposing factor for mastitis (because of the selection of resistant bacteria), the investigators would also like to test if administration of the strains to GBS-colonized pregnant women may lead to GBS eradication. Therefore, a mastitis-predisposing factor would de avoid.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Enrollment
100
9 log10 (colony-forming units), freeze-dried powder, daily for 30 week of pregnancy until birth
100 mg/once a day from 30 week of pregnancy until birth
Public Primary Health Care Centers network
Madrid, Madrid, Spain
RECRUITINGEvidence of clinical mastitis confirmed by microbiological cultures and somatic cell counts
Time frame: Weekly during the first 6 months after birth
Evidence of eradication og GBS colonization as confirmed by microbiological analysis of vaginal exudate and rectal swab
Time frame: At weeks 30, 35, 40 of pregnancy
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.